Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Kraig Biocraft Laboratories
AddedFeb 19, 2024
UpdatedJun 18, 2026
Kraig Biocraft Laboratories

Kraig Biocraft Laboratories

Public

Michigan-based Kraig Biocraft Laboratories develops high-strength, protein-based fibers for the textile industry using DNA technology.

HQ
Ann Arbor, MI, US
Founded
2006
Overview
Compare
Fundraising
Employees
Website

Kraig Biocraft Laboratories, founded in Ann Arbor, Michigan, focuses on developing high-strength, protein-based fibers for the textile and specialty fiber industries using recombinant DNA technology. The company's core mission is to revolutionize the production of technical fibers by leveraging spider silk technology, aiming to provide superior strength, toughness, and flexibility for military, industrial, and consumer applications. Their market focus includes high-performance technical fibers that meet stringent requirements for durability and versatility.

Notable affiliations include collaborations with the University of Notre Dame, which have facilitated significant breakthroughs in spider silk technologies. Kraig Biocraft Laboratories has garnered attention for its innovative approach and potential to disrupt traditional fiber markets. Key achievements include the successful development of scalable production methods for spider silk fibers, positioning the company as a leader in advanced material science. The overall impact of Kraig Biocraft Laboratories lies in its potential to transform multiple industries by providing a sustainable and high-performance alternative to conventional fibers.

Kraig Biocraft Laboratories - Quick Facts

When was Kraig Biocraft Laboratories founded?

Kraig Biocraft Laboratories was founded in 2006.

Where is Kraig Biocraft Laboratories' headquarters located?

Kraig Biocraft Laboratories' headquarters is located in Ann Arbor, MI, US.

When was Kraig Biocraft Laboratories' last funding round?

Kraig Biocraft Laboratories' most recent funding round was for $8M (USD) in November 2022.

How much has Kraig Biocraft Laboratories raised to-date?

As of Nov 21, 2022, Kraig Biocraft Laboratories has raised a total of $17.5M (USD).

How many employees does Kraig Biocraft Laboratories have?

Kraig Biocraft Laboratories has 30 employees as of Feb 6, 2024.

Kraig Biocraft Laboratories - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Software
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Textile Fibers
Tags
  • Materials
Unique IDs
  • ein: 830459707
  • secCik: 0001413119
  • ticker: KBLB
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2820Plastics Materials And Synthetic Resins, Synthetic Rubber, Cellulosic Manmade Fibers
  • 2800Chemicals And Allied Products
Show 8 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research